These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2143458)

  • 41. Renal and hemodynamic effects of isradipine in essential hypertension.
    Persson B; Andersson OK; Wysocki M; Hedner T; Aurell M
    Am J Med; 1989 Apr; 86(4A):60-4. PubMed ID: 2523657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative hemodynamic studies of isradipine and dihydralazine in atherosclerotic and normal rabbits.
    Hof RP; Hof A; Takiguchi Y
    J Cardiovasc Pharmacol; 1990; 15 Suppl 1():S13-22. PubMed ID: 1695297
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential effects of isradipine and atenolol on peripheral hemodynamics and arterial compliance.
    Jespersen LT; Krusell LR; Sihm I; Pedersen OL
    Am J Med; 1989 Apr; 86(4A):57-9. PubMed ID: 2523656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Isradipine in the treatment of hypertension: a clinical profile.
    Vidt DG
    Cleve Clin J Med; 1990; 57(8):677-84. PubMed ID: 2147874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of isradipine on peripheral hemodynamic reflex responses in mild-to-moderate essential hypertension.
    Duprez D; De Backer T; De Pue N; Hermans L; De Buyzere M; Clement DL
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):194S-196S. PubMed ID: 1827020
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The place of isradipine in the treatment of hypertension.
    Man in't Veld AJ
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):96S-102S. PubMed ID: 1827026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of isradipine in hypertension following coronary artery bypass surgery.
    Underwood SM; Feneck RO; Davies SW; Walesby RK; Lunnon MW
    Am J Med; 1989 Apr; 86(4A):81-7. PubMed ID: 2523661
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis.
    Survase S; Ivey ME; Nigro J; Osman N; Little PJ
    Vasc Health Risk Manag; 2005; 1(3):199-208. PubMed ID: 17319105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal effects of the new calcium channel blocking drug isradipine.
    Krämer BK; Häussler M; Ress KM; Müller GA; Burger KJ; Risler T
    Eur J Clin Pharmacol; 1990; 39(4):333-5. PubMed ID: 2150190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dose-response relationship and incidence of adverse drug reactions with isradipine in patients with essential hypertension.
    Simonsen K; Sundstedt CD
    Am J Med; 1989 Apr; 86(4A):91-3. PubMed ID: 2523663
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium antagonism in essential hypertension: effect on renal haemodynamics and microalbuminuria.
    Persson B; Andersson OK; Wysocki M; Hedner T; Karlberg B
    J Intern Med; 1992 Mar; 231(3):247-52. PubMed ID: 1532613
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelet-activating effect of low-density lipoprotein and its reversal by isradipine.
    Fetkovská N; Fedelesová V; Kozlovský M; Dzúrik R
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):175S-177S. PubMed ID: 1827014
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Beyond lowering of blood pressure. . .isradipine. Satellite symposium of the thirteenth scientific meeting of the International Society of Hypertension.
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):83S-209S. PubMed ID: 1827025
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals.
    Sauter A; Rudin M
    Am J Med; 1989 Apr; 86(4A):130-3. PubMed ID: 2523648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Isradipine for treatment of acute hypertension after myocardial revascularization.
    Brister NW; Barnette RE; Schartel SA; McClurken JB; Alpern J
    Crit Care Med; 1991 Mar; 19(3):334-8. PubMed ID: 1825628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Calcium-channel entry blocker therapy for hypertensive patients with concomitant renal impairment: a focus on isradipine.
    Frishman WH
    J Clin Pharmacol; 1994 Dec; 34(12):1164-72. PubMed ID: 7738211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isradipine in hypertension.
    Hansson L
    Drugs; 1990; 40 Suppl 2():10-4. PubMed ID: 2150633
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Isradipine-SRO: antihypertensive efficacy, central and peripheral hemodynamic effects in patients with hypertensive disease].
    Podzolkov VI; Bartieva DM; Makolkin VI
    Kardiologiia; 2003; 43(6):33-8. PubMed ID: 12891309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prevention of stroke and brain damage with calcium antagonists in animals.
    Sauter A; Rudin M
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):121S-127S. PubMed ID: 1827001
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isradipine--another calcium-channel blocker for the treatment of hypertension and angina.
    Lopez LM; Santiago TM
    Ann Pharmacother; 1992 Jun; 26(6):789-99. PubMed ID: 1535246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.